PMID: 9654386Jul 8, 1998Paper

Viral vectors, tools for gene transfer in the nervous system

Progress in Neurobiology
W T Hermens, J Verhaagen

Abstract

Viral vectors are becoming increasingly important tools to investigate the function of neural proteins and to explore the feasibility of gene therapy to treat diseases of the nervous system. This gene transfer technology is based on the use of a virus as a gene delivery vehicle. In contrast to functional analysis of gene products in transgenic mouse, viral vectors can be applied to transfer genes to somatic, post-mitotic cells of fully developed animals. To date, five viral vector systems are available for gene transfer in the nervous system. These include recombinant and defective herpes viral vectors, adenoviral vectors, adeno-associated viral vectors and lentiviral vectors. Of these vectors herpes and adenoviral vectors are the most common in use. To date, one of the main hurdles in applying these two vector systems is the focal immune response that occurs following intraparenchymal infusion. Despite this limitation, herpes and adenoviral vectors have been used successfully to modify the physiological response to injury in several rodent models of neurodegeneration. The first purpose of this review is to describe the principles of the generation of viral vectors and to discuss the advantages and disadvantages of the viral ve...Continue Reading

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C A LaughlinB J Carter
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·N Jones, T Shenk
Nov 1, 1977·Cell·R M EvansJ E Darnell
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H J FederoffJ A Kessler
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L RaoE White
Aug 1, 1992·The Journal of Clinical Investigation·L D Stratford-PerricaudetP Briand
Aug 1, 1991·Trends in Neurosciences·F H GageL J Fisher
Jan 1, 1991·Neuron·F H Gage, L J Fisher
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A I Geller, A Freese
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R M KotinK I Berns
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A I GellerA B Pardee
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D Y Ho, E S Mocarski
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C H SrivastavaA Srivastava
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J A WolffT Friedmann
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H S GinsbergG A Prince

❮ Previous
Next ❯

Citations

Feb 11, 1999·Journal of Neuroscience Research·G M Smith, M I Romero
Jan 29, 2002·Journal of Neuroscience Research·Zhennan Lai, Roscoe O Brady
Aug 24, 2004·Cell and Tissue Research·O Eberhardt, J B Schulz
Sep 1, 2000·Brain Research. Brain Research Reviews·K E van EsseveldtG J Boer
Mar 14, 2001·Brain Research. Brain Research Reviews·R J Pasterkamp, J Verhaagen
Oct 21, 2000·Journal of Neuroscience Methods·B Y WuA C Yu
Aug 16, 2000·Advanced Drug Delivery Reviews·S R WinnJ O Hollinger
Nov 5, 2002·Methods : a Companion to Methods in Enzymology·Marc J RuitenbergJoost Verhaagen
Mar 17, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stefany D PrimeauxMarlene A Wilson
Sep 21, 2000·The European Journal of Neuroscience·A B HuberC Brösamle
Jul 25, 2000·Journal of the Peripheral Nervous System : JPNS·M J Eaton
Jul 31, 1999·Human Gene Therapy·P D SimonE B Dreyer
Apr 13, 2004·Neuroreport·Mimoun AzzouzNicholas D Mazarakis
Apr 12, 2007·International Anesthesiology Clinics·Shuanglin HaoDavid J Fink
Jul 14, 2006·Artificial Organs·Yi-Cheng Huang, Yi-You Huang
Jan 18, 2007·Molecular Medicine·Tobias HirschLars Steinstraesser
Oct 2, 2014·Neuromolecular Medicine·Nitish D FagoeJoost Verhaagen
Oct 2, 2012·Journal of Neuroscience Methods·Nicholas NagykeryChangiz Geula
Mar 18, 2008·Neuroscience Letters·Hideaki NakajimaHisatoshi Baba
Jan 4, 2012·The European Journal of Neuroscience·Vanessa S BoyceLorne M Mendell
May 25, 2002·The Journal of General Virology·Johan SkogGöran Wadell
Feb 19, 2002·Expert Opinion on Biological Therapy·Hoang N Le, David M Frim
Dec 15, 2010·Molecular and Cellular Neurosciences·M HellströmA R Harvey
Dec 1, 2001·Expert Opinion on Biological Therapy·S PandyaV Planelles
Jan 5, 2001·Expert Opinion on Investigational Drugs·D M Frim, U J Kang
Nov 4, 2000·Expert Opinion on Investigational Drugs·N Gupta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.